| 1 |
34711160 | Advances in Pyrazole Based Scaffold as Cyclin-dependent Kinase 2 Inhibitors for the Treatment of Cancer. | 2022 |
1 |
| 2 |
34243605 | Pyrazole ring-containing isolongifolanone derivatives as potential CDK2 inhibitors: Evaluation of anticancer activity and investigation of action mechanism. | 2021 Jul |
1 |
| 3 |
30682722 | Design, synthesis and biological evaluation of certain CDK2 inhibitors based on pyrazole and pyrazolo[1,5-a] pyrimidine scaffold with apoptotic activity. | 2019 May |
2 |
| 4 |
30218747 | Targeting apoptosis by 1,2-diazole through regulation of EGFR, Bcl-2 and CDK-2 mediated signaling pathway in human non-small cell lung carcinoma A549 cells. | 2018 Dec 30 |
4 |
| 5 |
28024230 | In silico study of porphyrin-anthraquinone hybrids as CDK2 inhibitor. | 2017 Apr |
1 |
| 6 |
23933045 | Synthesis, biological evaluation and molecular docking studies of pyrazole derivatives coupling with a thiourea moiety as novel CDKs inhibitors. | 2013 Oct |
2 |
| 7 |
17125195 | Prediction of multiple binding modes of the CDK2 inhibitors, anilinopyrazoles, using the automated docking programs GOLD, FlexX, and LigandFit: an evaluation of performance. | 2006 Nov-Dec |
2 |